115 related articles for article (PubMed ID: 18521543)
1. Aurocyanide, dicyano-aurate (I), a pharmacologically active metabolite of medicinal gold complexes.
Graham GG; Whitehouse MW; Bushell GR
Inflammopharmacology; 2008 Jun; 16(3):126-32. PubMed ID: 18521543
[TBL] [Abstract][Full Text] [Related]
2. The activation of gold complexes by cyanide produced by polymorphonuclear leukocytes. III. The formation of aurocyanide by myeloperoxidase.
Graham GG; Kettle AJ
Biochem Pharmacol; 1998 Aug; 56(3):307-12. PubMed ID: 9744567
[TBL] [Abstract][Full Text] [Related]
3. Redox and ligand exchange reactions of potential gold(I) and gold(III)-cyanide metabolites under biomimetic conditions.
Canumalla AJ; Al-Zamil N; Phillips M; Isab AA; Shaw CF
J Inorg Biochem; 2001 May; 85(1):67-76. PubMed ID: 11377697
[TBL] [Abstract][Full Text] [Related]
4. Redox Chemistry and [Au(CN)(2)] in the Formation of Gold Metabolites.
Shaw Iii GF; Schraa S; Gleichmann E; Grover YP; Dunemann L; Jagarlamudi A
Met Based Drugs; 1994; 1(5-6):351-62. PubMed ID: 18476255
[TBL] [Abstract][Full Text] [Related]
5. The activation of gold complexes by cyanide produced by polymorphonuclear leukocytes--II. Evidence for the formation and biological activity of aurocyanide.
Graham GG; Dale MM
Biochem Pharmacol; 1990 Jun; 39(11):1697-702. PubMed ID: 2160818
[TBL] [Abstract][Full Text] [Related]
6. Glutathionato-S-Gold(III) complexes formed as intermediates in the reduction of auricyanide by glutathione.
Yangyuoru PM; Webb JW; Shaw CF
J Inorg Biochem; 2008 Mar; 102(3):584-93. PubMed ID: 18255156
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization and anticancer activity in vitro evaluation of novel dicyanoaurate (I)-based complexes.
Karadağ A; Aydın A; Tekin Ş; Akbaş H; Şahin O; Sen F
Life Sci; 2020 Jun; 251():117635. PubMed ID: 32272179
[TBL] [Abstract][Full Text] [Related]
8. A mass spectrometric investigation of the binding of gold antiarthritic agents and the metabolite [Au(CN)2]- to human serum albumin.
Talib J; Beck JL; Ralph SF
J Biol Inorg Chem; 2006 Jul; 11(5):559-70. PubMed ID: 16791640
[TBL] [Abstract][Full Text] [Related]
9. Proton-linked bi- and tri-metallic gold cyanide complexes observed by ESI-MS spectrometry.
Yangyuoru PM; Webb JW; Shaw CF
J Inorg Biochem; 2008 Mar; 102(3):576-83. PubMed ID: 18255157
[TBL] [Abstract][Full Text] [Related]
10. The cellular metabolism and effects of gold complexes.
Graham GG; Champion GD; Ziegler JB
Met Based Drugs; 1994; 1(5-6):395-404. PubMed ID: 18476258
[TBL] [Abstract][Full Text] [Related]
11. Alteration of a model antigen by Au(III) leads to T cell sensitization to cryptic peptides.
Griem P; Panthel K; Kalbacher H; Gleichmann E
Eur J Immunol; 1996 Feb; 26(2):279-87. PubMed ID: 8617292
[TBL] [Abstract][Full Text] [Related]
12. End-on and side-on π-acid ligand adducts of gold(I): carbonyl, cyanide, isocyanide, and cyclooctyne gold(I) complexes supported by N-heterocyclic carbenes and phosphines.
Celik MA; Dash C; Adiraju VA; Das A; Yousufuddin M; Frenking G; Dias HV
Inorg Chem; 2013 Jan; 52(2):729-42. PubMed ID: 23273108
[TBL] [Abstract][Full Text] [Related]
13. Medicinal chemistry of gold.
Graham GG; Ziegler JB; Champion GD
Agents Actions Suppl; 1993; 44():209-17. PubMed ID: 8103963
[TBL] [Abstract][Full Text] [Related]
14. Competitive Substitution and Electron Transfer in Reactions between Haloamminegold(III) and Halocyanoaurate(III) Complexes and Thiocyanate.
Elmroth SK; Elding LI
Inorg Chem; 1996 Apr; 35(8):2337-2342. PubMed ID: 11666433
[TBL] [Abstract][Full Text] [Related]
15. Non-covalent binding of the heavy atom compound [Au(CN)2]- at the halide binding site of haloalkane dehalogenase from Xanthobacter autotrophicus GJ10.
Verschueren KH; Franken SM; Rozeboom HJ; Kalk KH; Dijkstra BW
FEBS Lett; 1993 Jun; 323(3):267-70. PubMed ID: 8500621
[TBL] [Abstract][Full Text] [Related]
16. Is local biotransformation the key to understanding the pharmacological activity of salicylates and gold drugs?
Whitehouse MW; Graham GG
Inflamm Res; 1996 Dec; 45(12):579-82. PubMed ID: 8988401
[TBL] [Abstract][Full Text] [Related]
17. Chrysotherapy: a synoptic review.
Eisler R
Inflamm Res; 2003 Dec; 52(12):487-501. PubMed ID: 14991077
[TBL] [Abstract][Full Text] [Related]
18. 1H, 13C NMR, and electronic absorption spectroscopic studies of the interaction of cyanide with aurothiomalate.
Graham GG; Bales JR; Grootveld MC; Sadler PJ
J Inorg Biochem; 1985 Nov; 25(3):163-73. PubMed ID: 3934340
[TBL] [Abstract][Full Text] [Related]
19. Dicyanogold (I) is a common human metabolite of different gold drugs.
Elder RC; Zhao Z; Zhang Y; Dorsey JG; Hess EV; Tepperman K
J Rheumatol; 1993 Feb; 20(2):268-72. PubMed ID: 8474063
[TBL] [Abstract][Full Text] [Related]
20. Toward rational construction of gold, gold-silver, and gold-mercury string complexes: syntheses, structures, and properties of [Au(Tab)2]2L2 (L = I and PF6), {[(Tab)2M][Au(CN)2]}2 (M = Au and Ag), and {[Hg(Tab)2][Au(CN)2]2} [Tab = 4-(trimethylammonio)benzenethiolate].
Chen JX; Zhang WH; Tang XY; Ren ZG; Li HX; Zhang Y; Lang JP
Inorg Chem; 2006 Sep; 45(19):7671-80. PubMed ID: 16961358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
